Here, our results in vitro in ESCC cell lines shows that EP300 function as an oncogene exerting tumor promotion effects, which has been demonstrated in lung, colon, prostate and breast cancers18-21. This evidence concerns the gene EP300 and esophageal squamous cell carcinoma.